Retraction notice to "Research progress of indole-fused derivatives as allosteric modulators: Opportunities for drug development" [Biomedicine & Pharmacotherapy 162 (2023) 114574] - 25/03/26
Doi : 10.1016/j.biopha.2026.119210
Meng-Lan Luo a, Qian Zhao a, ⁎, Xiang-Hong He a, Xin Xie a, Hong-Ping Zhu a, b, Feng-Ming You a, Cheng Peng a, Gu Zhan a, ⁎, Wei Huang a, ⁎
a State Key Laboratory of Southwestern Chinese Medicine Resources, TCM Regulating Metabolic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu University of Traditional Chinese Medicine, Chengdu, China
b Antibiotics Research and Re-evaluation Key Laboratory of Sichuan Province, Sichuan Industrial Institute of Antibiotics, Chengdu University, Chengdu, China
⁎ Corresponding authors.
Le texte complet de cet article est disponible en PDF.
© 2026
The Authors. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 197
Article 119210- avril 2026 Retour au numéro
Article précédent
- Retraction notice to "Bioactive compounds and their libraries: An insight into prospective phytotherapeutics approach for oral mucocutaneous cancers" [Biomedicine & Pharmacotherapy 141 (2021) 111809]
- Henry A. Adeola, Afsareen Bano, Ravina Vats, Amit Vashishtha, Deepika Verma, Deepak Kaushik, Vineet Mittal, Md. Habibur Rahman, Agnieszka Najda, Ghadeer M. Albadrani, Amany A. Sayed, Sameh M. Farouk, Emad H.M. Hassanein, Muhammad Furqan Akhtar, Ammara Saleem, Mohamed M. Abdel-Daim, Rashmi Bhardwaj
- Retraction notice to "Interplays between non-coding RNAs and chemokines in digestive system cancers" [Biomedicine & Pharmacotherapy 152 (2022) 113237]
- Abdollah Jafarzadeh, Seyedvahid Seyedmoalemi, Amirreza Dashti, Maryam Nemati, Sara Jafarzadeh, Najmeh Aminizadeh, Massoud Vosough, Ali Rajabi, Ali Afrasiabi, Hamed Mirzaei
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?